Medicare Enrolled

Dr. Adrian Lavina, MD

Ophthalmology · Palm Beach Gardens, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3399 PGA BLVD, Palm Beach Gardens, FL 33410
5616240099
Registered in NPPES since 2006
NPI: 1447279609 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lavina from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lavina? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lavina

Dr. Adrian Lavina is an ophthalmology specialist in Palm Beach Gardens, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lavina performed 44,537 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Lavina received a total of $21,928 from 28 pharmaceutical and/or device companies across 212 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lavina is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 3% volume in FL $21,928 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 87171 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
44,537
Medicare services
Top 3% in FL for ophthalmology
Not available
Unique patients (not deduplicated)
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
34,380 $29 $45
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,403 $31 $63
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,669 $92 $742
Aflibercept eye injection (Eylea) 1,634 $692 $1,080
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
998 $93 $154
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
905 $29 $46
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
741 $67 $110
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
345 $120 $184
Injection, ranibizumab, 0.1 mg 311 $181 $299
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
292 $12 $19
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
195 $64 $250
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
188 $39 $64
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
180 $132 $208
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
107 $106 $167
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
91 $19 $30
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
49 $1,668 $2,455
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
26 $91 $181
Removal of retinal membrane
A surgical procedure to remove a membrane from the surface of the retina.
12 $939 $1,405
Complex detached retina repair with eye fluid drainage
A surgical procedure to repair a detached retina and drain fluid located between the lens and the retina.
11 $1,093 $1,631
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,928
Total received (2018-2024)
Avg $3,133/year across 7 years
Top 9% in FL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
212
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,554
2023
$1,997
2022
$2,747
2021
$1,706
2020
$585
2019
$7,805
2018
$5,534

Payments by company (2024)

Regeneron Healthcare Solutions, Inc.
$396
Astellas Pharma US Inc
$258
ABBVIE INC.
$145
ANI Pharmaceuticals, Inc.
$145
Rayner Intraocular Lenses Limited
$138
Regeneron Pharmaceuticals, Inc.
$108
Astellas Pharma Global Development
$106
Apellis Pharmaceuticals, Inc.
$94
Genentech USA, Inc.
$84
Alimera Sciences, Inc.
$58
Alcon Vision LLC
$22
Top 3 companies account for 51.4% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$5,951
Genentech USA, Inc.
$5,654
US Retina LLC
$2,997
Regeneron Healthcare Solutions, Inc.
$2,380
ABBVIE INC.
$587
Apellis Pharmaceuticals, Inc.
$526
Astellas Pharma US Inc
$517
Novartis Pharmaceuticals Corporation
$406
EyePoint Pharmaceuticals US, Inc.
$405
Horizon Therapeutics plc
$328
Regeneron Pharmaceuticals, Inc.
$313
Dutch Ophthalmic, USA
$299
Omeros Corporation
$254
Alimera Sciences, Inc.
$175
Genentech, Inc.
$165
Kala Pharmaceuticals, Inc.
$145
ANI Pharmaceuticals, Inc.
$145
Rayner Intraocular Lenses Limited
$138
Astellas Pharma Global Development
$106
Aerie Pharmaceuticals, Inc.
$105
NEW WORLD MEDICAL,INC.
$81
Hoffmann-La Roche Limited
$80
Allergan, Inc.
$53
Alcon Vision LLC
$47
Sun Pharmaceutical Industries Inc.
$22
Bausch & Lomb, a division of Bausch Health US, LLC
$22
Bausch & Lomb Americas Inc.
$14
Biogen, Inc.
$14
Top 3 companies account for 66.6% of all-time payments
Associated products mentioned in payments ›
Ahmed Glaucoma Valve · BEOVU · BROMSITE · BUPARLISIB · Constellation · DEXYCU · DURYSTA · EVA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · INVELTYS · Iluvien · Izervay · Lucentis · Non-Covered Product · OMIDRIA · OZURDEX · Omidria · PURIFIED CORTROPHIN GEL · RayOne EMV · Rhopressa · SUSVIMO · Susvimo · Syfovre · TEPEZZA · VABYSMO · VISUDYNE · Vabysmo · XIIDRA · XIPERE · YUTIQ · combined machine
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Palm Beach Gardens?
Compare ophthalmologists in the Palm Beach Gardens area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
103
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
PALM BEACH GARDENS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lavina is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lavina experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Lavina performed 34,380 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lavina receive payments from pharmaceutical companies?
Yes. Dr. Lavina received a total of $21,928 from 28 companies across 212 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lavina's costs compare to other ophthalmologists in Palm Beach Gardens?
Dr. Lavina's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lavina) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →